Recombinant Human IL-4 Protein，His

Interleukin-4 (IL-4) is a crucial cytokine in the immune system, primarily produced by T helper cells, mast cells, and basophils. It plays a vital role in regulating immune responses, particularly in promoting the differentiation of naive T cells into Th2 cells and enhancing the production of IgE antibodies, which are essential in allergic responses and asthma pathogenesis. Given its significant role in immune modulation, IL-4 has been a target for therapeutic interventions aimed at treating various allergic diseases, autoimmune disorders, and even certain cancers. The development of recombinant IL-4 proteins has paved the way for in-depth studies on its functions and mechanisms. Researchers have focused on generating IL-4 variants with modified properties, such as altered receptor binding affinity or enhanced stability, to improve their therapeutic efficacy. These recombinant proteins are not only useful in understanding IL-4's biological functions through in vitro and in vivo studies but also serve as potential candidates in designing targeted therapies for conditions characterized by dysregulated IL-4 signaling. Furthermore, the exploration of IL-4’s interactions with other immune pathways has revealed its complex role in balancing immune responses, highlighting the importance of continued research in this area. The ongoing investigation of IL-4 and its recombinant forms may lead to novel strategies for managing immune-related diseases, thus contributing meaningfully to the field of immunotherapy and beyond.